IKT
Inhibikase Therapeutics, Inc.
+0.04 (+1.73%)2.35USD208K成交股數328M市值–本益比(近四季)88.3股價營收比–營收年增(近四季)2026-11-13下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100% | 0.00-100% | 0.00-100% | 0.00 | 80K | 116K | 65K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 13.4M | 10.8M | 7.6M | 5.3M | 10.5M | 7.2M | 4.2M | 3.1M | 2.8M | 3.2M | 4.5M | 2.9M |
| 銷售管理費用 | 7.7M | 7.4M | 5.6M | 5.9M | 5.2M | 5.7M | 1.6M | 2.0M | 2.0M | 1.6M | 1.8M | 1.9M |
| 營業利益 | −21.1M+44% | −17.8M+38% | −12.8M+119% | −10.8M+114% | −14.6M+205% | −12.9M+171% | −5.8M-6% | −5.1M+7% | −4.8M | −4.8M | −6.2M | −4.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | -5,993.4% | -5,328.1% | -7,307.6% |
| 稅後淨利 | −19.6M+43% | −16.4M+35% | −11.9M+106% | −9.9M+100% | −13.7M+194% | −12.1M+164% | −5.8M+0% | −5.0M+11% | −4.6M | −4.6M | −5.8M | −4.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | -5,775.1% | -4,963.5% | -6,940.0% |
| 稀釋 EPS | -0.11-27% | -0.10-111% | -0.13-80% | -0.11-83% | -0.15-79% | 0.88-202% | -0.65-41% | -0.66-33% | -0.73 | -0.86 | -1.11 | -0.98 |
| 稀釋股數 | 175M | 172M | 90.1M | 90.0M | 89.5M | 23.7M | 8.9M | 7.5M | 6.3M | 5.3M | 5.2M | 4.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 31.2M | 49.6M | 38.3M | 77.7M | 73.4M | 97.5M | 913K | 3.1M | 2.4M | 14.9M | 1.9M | 4.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 164M | 173M | 79.6M | 88.9M | 94.3M | 98.6M | 4.4M | 8.8M | 11.1M | 17.9M | 22.3M | 28.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 10.3M | 5.7M | 6.7M | 8.8M | 8.6M | 3.7M | 4.9M | 3.7M | 4.3M | 2.9M | 2.9M | 2.8M |
| 股東權益 | 153M | 168M | 72.9M | 80.1M | 85.7M | 94.9M | −531K | 5.1M | 6.8M | 15.0M | 19.5M | 25.3M |
| 負債比 | 6.3% | 3.3% | 8.4% | 9.9% | 9.1% | 3.8% | 112.1% | 42.3% | 38.8% | 16.0% | 12.9% | 10.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −12.1M | – | – | −4.1M+6% | – | – | – | −3.9M | – | – | −6.0M |
| 資本支出 | – | 0.00 | – | – | 13K | – | – | – | 0.00 | – | – | – |
| 自由現金流 | – | −12.1M | – | – | −4.1M+6% | – | – | – | −3.9M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2020 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2020 年度 · 698K
| Grant | 698K | 100.0% | -37.8% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.7M | – | −48.3M | -1,299.0% | -0.49 | −27.8M |
| FY2024 | 0.00 | -100.0% | −27.5M | –% | -1.16 | −19.1M |
| FY2023 | 261K | +111.0% | −19.0M | -7,304.7% | -3.16 | −18.1M |
| FY2022 | 123K | -96.0% | −18.1M | -14,625.9% | -4.28 | −17.6M |
| FY2021 | 3.1M | +343.9% | −14.8M | -476.9% | -0.81 | −14.3M |
| FY2020 | 698K | – | −2.8M | -407.7% | -0.35 | – |